ET
Therapeutic Areas
MicroQuin Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Oncology Program | All Cancers | Pre-clinical |
| Anti-Viral Program | Viral Infections | Pre-clinical |
| Neuro Program | Neurodegeneration / Traumatic Brain Injury | Pre-clinical |
Leadership Team at MicroQuin
DS
Dr. Scott Robinson
Founder & CEO
DA
Dr. Alan Barge
Medical - Oncology
DA
Dr. Agnes Kiu Webber
Medical & Regulatory
DK
Dr. Keith Wilcoxen
Chemist
DP
Dr. Peter Sennhenn
Chemist
DY
Dr. Yohei Yamauchi
Scientific - Viral
PA
Prof. Ann Williams
Scientific - Oncology
DR
Dr. Ross Soo
Medical - Oncology